Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions

被引：146
作者：
Delgado, Mario [1 ]
Ganea, Doina [2 ]
机构：
[1] IPBLN CSIC, Inst Parasitol & Biomed, Granada, Spain
[2] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19122 USA
来源：
AMINO ACIDS | 2013年 / 45卷 / 01期
关键词：
Vasoactive intestinal peptide; Autoimmunity; Inflammation; Neuroinflammation; Neuropeptides/neurotransmitters; CYCLASE-ACTIVATING POLYPEPTIDE; REGULATORY DENDRITIC CELLS; MEKK1/MEK4/JNK SIGNALING PATHWAY; T-CELLS; CHEMOKINE PRODUCTION; INDUCED NEURODEGENERATION; EXPERIMENTAL ARTHRITIS; RHEUMATOID-ARTHRITIS; ALTERED EXPRESSION; CUTTING EDGE;
D O I：
10.1007/s00726-011-1184-8
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Vasoactive intestinal peptide (VIP), a 28-amino acid neuropeptide/neurotransmitter, is widely distributed in both the central and peripheral nervous system. VIP is released by both neurons and immune cells. Various cell types, including immune cells, express VIP receptors. VIP has pleiotropic effects as a neurotransmitter, immune regulator, vasodilator and secretagogue. This review is focused on VIP production and effects on immune cells, VIP receptor signaling as related to immune functions, and the involvement of VIP in inflammatory and autoimmune disorders. The review addresses present clinical use of VIP and future therapeutic directions.
引用
收藏
页码：25 / 39
页数：15
相关论文
共 124 条
[61]   Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy [J].
Gonzalez-Rey, Elena ;
Anderson, Per ;
Delgado, Mario .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 :70-76
[62]   Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders? [J].
Gonzalez-Rey, Elena ;
Delgado, Mario .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (09) :482-491
[63]   Neuropeptides: keeping the balance between pathogen immunity and immune tolerance [J].
Gonzalez-Rey, Elena ;
Ganea, Doina ;
Delgado, Mario .
CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (04) :473-481
[64]   From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP - A view of neuroprotection and cell division [J].
Gozes, I ;
Divinsky, I ;
Pilzer, I ;
Fridkin, M ;
Brenneman, DE ;
Spier, AD .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2003, 20 (03) :315-322
[65]   INTERACTION OF VASOACTIVE INTESTINAL PEPTIDE WITH HUMAN-BLOOD MONONUCLEAR-CELLS [J].
GUERRERO, JM ;
PRIETO, JC ;
ELORZA, FL ;
RAMIREZ, R ;
GOBERNA, R .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1981, 21 (02) :151-160
[66]   VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts [J].
Gutiérrez-Cañas, I ;
Juarranz, Y ;
Santiago, B ;
Arranz, A ;
Martinez, C ;
Galindo, M ;
Payá, M ;
Gomariz, RP ;
Pablos, JL .
RHEUMATOLOGY, 2006, 45 (05) :527-532
[67]   Clues to VIP function from knockout mice [J].
Hamidi, S. A. ;
Szema, A. M. ;
Lyubsky, S. ;
Dickman, K. G. ;
Degene, A. ;
Mathew, S. M. ;
Waschek, J. A. ;
Said, S. I. .
VIP, PACAP, AND RELATED PEPTIDES: FROM GENE TO THERAPY, 2006, 1070 :5-9
[68]  
Harmar AJ, 1998, PHARMACOL REV, V50, P265
[69]   Vasoactive intestinal peptide: cardiovascular effects [J].
Henning, RJ ;
Sawmiller, DR .
CARDIOVASCULAR RESEARCH, 2001, 49 (01) :27-37
[70]   Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophages [J].
Herrera, Juan Luis ;
Gonzalez-Rey, Elena ;
Fernandez-Montesinos, Rafael ;
Quintana, Francisco J. ;
Najmanovich, Rafael ;
Pozo, David .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (9B) :3209-3217
234567891011